Off-label uses for CCBs include migraine headaches, Raynaud phenomenon (RP), and subarachnoid hemorrhage. CCBs do not treat depression; in fact, their use has been associated with depression. A recent cohort study found that CCB use in patients with atrial fibrillation (AF) increased incidence of ischemic strokes. The most common CCBs are relatively weight neutral.
Learn more about RP.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L. Windle. Rapid Rx Quiz: Calcium Channel Blockers - Medscape - Oct 17, 2022.